Stage III Breast Cancer Recruiting Phase 1 / 2 Trials for Binimetinib (DB11967)

IndicationStatusPhase
DBCOND0031775 (Stage III Breast Cancer)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs